Home » Topics » Regulatory » EMA

EMA
RSS

EMA committee issues negative opinion on Portola's betrixaban

March 26, 2018

Juluca receives positive opinion from EMA's CHMP

March 26, 2018

EMA committee backs approval of Sandoz's biosimilar infliximab

March 26, 2018

EMA committee hands down positive opinion for Cabometyx

March 23, 2018

Soligenix receives E.U. orphan designation for RiVax

March 23, 2018

EMA reports negative CHMP assessment for abaloparatide-SC

March 23, 2018

Immunicum obtains ATMP certificate from EMA for ilixadencel

March 21, 2018

EMA accepts type II variation application for Xtandi in non-metastatic CRPC

March 19, 2018

EMA validates MAA for Xyndari for sickle cell disease

March 13, 2018

Sigilon Therapeutics' SIG-003 awarded EMA ATMP designation

March 12, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 22, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
Psychedelic space expanding on Trump’s EO
BioWorld
Timothy Leary is dead, but he could be on the outside looking in with a smile on his face as U.S. President Donald Trump’s latest executive order (EO) fuels a...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...
In the clinic for April 21, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Abbott, Agenus, Astrazeneca, Briacell, Clearmind, Greenwich, Intodna,...